Pacific Edge PFGTF Stock
Pacific Edge Price Chart
Pacific Edge PFGTF Financial and Trading Overview
| Pacific Edge stock price | 0.06 USD |
| Previous Close | 0.08 USD |
| Open | 0.08 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.08 - 0.08 USD |
| 52 Week Range | 0.06 - 0.34 USD |
| Volume | 2.55K USD |
| Avg. Volume | 231 USD |
| Market Cap | 65.73M USD |
| Beta (5Y Monthly) | 0.745647 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PFGTF Valuation Measures
| Enterprise Value | -10836243 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.12522 |
| Price/Book (mrq) | 0.7952451 |
| Enterprise Value/Revenue | -0.515 |
| Enterprise Value/EBITDA | 0.344 |
Trading Information
Pacific Edge Stock Price History
| Beta (5Y Monthly) | 0.745647 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.34 USD |
| 52 Week Low | 0.06 USD |
| 50-Day Moving Average | 0.1 USD |
| 200-Day Moving Average | 0.24 USD |
PFGTF Share Statistics
| Avg. Volume (3 month) | 231 USD |
| Avg. Daily Volume (10-Days) | 254 USD |
| Shares Outstanding | 810.36M |
| Float | 742.86M |
| Short Ratio | N/A |
| % Held by Insiders | 8.31% |
| % Held by Institutions | 37.68% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -128.20% |
| Operating Margin (ttm) | -152.40% |
| Gross Margin | 55.55% |
| EBITDA Margin | -149.57% |
Management Effectiveness
| Return on Assets (ttm) | -19.43% |
| Return on Equity (ttm) | -28.21% |
Income Statement
| Revenue (ttm) | 21.03M USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | 65.00% |
| Gross Profit (ttm) | 11.68M USD |
| EBITDA | -31461000 USD |
| Net Income Avi to Common (ttm) | -26965000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 77.79M USD |
| Total Cash Per Share (mrq) | 0.1 USD |
| Total Debt (mrq) | 1.22M USD |
| Total Debt/Equity (mrq) | 1.48 USD |
| Current Ratio (mrq) | 11.109 |
| Book Value Per Share (mrq) | 0.102 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25575000 USD |
| Levered Free Cash Flow (ttm) | -19389000 USD |
Profile of Pacific Edge
| Country | United States |
| State | N/A |
| City | Dunedin |
| Address | Centre for Innovation |
| ZIP | 9016 |
| Phone | 64 3 479 5800 |
| Website | https://www.pacificedgedx.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 114 |
Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. The company operates in two segments, Commercial and Research. It offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. The company is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, it is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. The company was incorporated in 2001 and is headquartered in Dunedin, New Zealand.
Q&A For Pacific Edge Stock
What is a current PFGTF stock price?
Pacific Edge PFGTF stock price today per share is 0.06 USD.
How to purchase Pacific Edge stock?
You can buy PFGTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pacific Edge?
The stock symbol or ticker of Pacific Edge is PFGTF.
Which industry does the Pacific Edge company belong to?
The Pacific Edge industry is Diagnostics & Research.
How many shares does Pacific Edge have in circulation?
The max supply of Pacific Edge shares is 884.09M.
What is Pacific Edge Price to Earnings Ratio (PE Ratio)?
Pacific Edge PE Ratio is now.
What was Pacific Edge earnings per share over the trailing 12 months (TTM)?
Pacific Edge EPS is -0.02 USD over the trailing 12 months.
Which sector does the Pacific Edge company belong to?
The Pacific Edge sector is Healthcare.